Zobrazeno 1 - 10 of 239 pro vyhledávání: '"Ad Barrett"'
3
Akademický článek
Probable Dapagliflozin-Associated Acute Pancreatitis.
Autor: Barrett AD; Advanced Vital Care Pharmacy: Home Infusion and Infusion Services, Amarillo, TX.; Southwestern Oklahoma State University College of Pharmacy, Weatherford, OK., Pitts MA; Southwestern Oklahoma State University College of Pharmacy, Weatherford, OK.; Stillwater Medical Center, Stillwater, OK., Myers EM; Southwestern Oklahoma State University College of Pharmacy, Weatherford, OK.; Jackson County Memorial Hospital, Altus, OK., Johnson JL; Department of Pharmacy Practice, Southwestern Oklahoma State University College of Pharmacy, Weatherford, OK.; Department of Internal Medicine, Oklahoma State University Center for Health Sciences, Tulsa, OK.
Publikováno v: Diabetes spectrum : a publication of the American Diabetes Association [Diabetes Spectr] 2022 Spring; Vol. 35 (2), pp. 232-238. Date of Electronic Publication: 2021 Sep 28.
Zobrazit plný text záznamu
4
Akademický článek
The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control.
Autor: Vannice KS; Consultant, PATH, Seattle, WA, USA., Hills SL; Arboviral Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, CO, USA., Schwartz LM; Schwartz Consulting, Seattle, WA, USA., Barrett AD; Sealy Institute for Vaccine Sciences, Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA., Heffelfinger J; WHO Regional Office for the Western Pacific, Manila, Philippines., Hombach J; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Letson GW; PATH, Seattle, WA, USA., Solomon T; National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, and Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.; Walton Centre NHS Foundation Trust, Liverpool, UK., Marfin AA; PATH, Seattle, WA, USA. aamarfin@path.org.
Publikováno v: NPJ vaccines [NPJ Vaccines] 2021 Jun 15; Vol. 6 (1), pp. 82. Date of Electronic Publication: 2021 Jun 15.
Zobrazit plný text záznamu
5
Akademický článek
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.
Autor: Juan-Giner A; Epicentre, Paris, France., Kimathi D; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Grantz KH; Department of Biology, University of Florida, Gainesville, FL, USA; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Hamaluba M; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Kazooba P; Epicentre Mbarara Research Centre, Mbarara, Uganda., Njuguna P; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Fall G; Institut Pasteur Dakar, Dakar, Senegal., Dia M; Institut Pasteur Dakar, Dakar, Senegal., Bob NS; Institut Pasteur Dakar, Dakar, Senegal., Monath TP; Crozet BioPharma LLC, Devens, MA, USA., Barrett AD; Sealy Institute for Vaccines Sciences and Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA., Hombach J; Immunization, Vaccines & Biologicals, WHO, Geneva, Switzerland., Mulogo EM; Department of Community Health, Mbarara University of Science & Technology, Mbarara, Uganda., Ampeire I; Expanded Program on Immunization, Ministry of Health, Kampala, Uganda., Karanja HK; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya., Nyehangane D; Epicentre Mbarara Research Centre, Mbarara, Uganda., Mwanga-Amumpaire J; Epicentre Mbarara Research Centre, Mbarara, Uganda., Cummings DAT; Department of Biology, University of Florida, Gainesville, FL, USA; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA., Bejon P; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Warimwe GM; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Grais RF; Epicentre, Paris, France. Electronic address: rebecca.grais@epicentre.msf.org.
Publikováno v: Lancet (London, England) [Lancet] 2021 Jan 09; Vol. 397 (10269), pp. 119-127.
Zobrazit plný text záznamu
6
Akademický článek
Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality.
Autor: Maciejewski S; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 20892, USA., Ruckwardt TJ; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Morabito KM; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Foreman BM; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 20892, USA., Burgomaster KE; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 20892, USA., Gordon DN; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 20892, USA., Pelc RS; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 20892, USA., DeMaso CR; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 20892, USA., Ko SY; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Fisher BE; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Yang ES; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Nair D; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Foulds KE; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Todd JP; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Kong WP; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Roy V; Ragon Institute, Cambridge, MA 02139, USA., Aleshnick M; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 20892, USA., Speer SD; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 20892, USA., Bourne N; Department of Microbiology and Immunology, Department of Pathology, Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA., Barrett AD; Department of Microbiology and Immunology, Department of Pathology, Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA., Nason MC; Biostatistics Research Branch, Division of Clinical Research, NIAID, NIH, Bethesda, MD 20852, USA., Roederer M; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Gaudinski MR; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Chen GL; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Dowd KA; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 20892, USA., Ledgerwood JE; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Alter G; Ragon Institute, Cambridge, MA 02139, USA., Mascola JR; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA., Graham BS; Vaccine Research Center, NIAID, NIH, Bethesda, MD 20892, USA. piersontc@mail.nih.gov bgraham@mail.nih.gov., Pierson TC; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 20892, USA. piersontc@mail.nih.gov bgraham@mail.nih.gov.
Publikováno v: Science translational medicine [Sci Transl Med] 2020 Jun 10; Vol. 12 (547).
Zobrazit plný text záznamu
7
Akademický článek
Current status of Severe Fever with Thrombocytopenia Syndrome vaccine development.
Autor: Reece LM; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA., Beasley DW; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA; Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, TX, USA., Milligan GN; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; Department of Pediatrics, University of Texas Medical Branch, Galveston, TX, USA., Sarathy VV; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA., Barrett AD; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: abarrett@utmb.edu.
Publikováno v: Current opinion in virology [Curr Opin Virol] 2018 Apr; Vol. 29, pp. 72-78. Date of Electronic Publication: 2018 Apr 09.
Zobrazit plný text záznamu
8
Akademický článek
Zika, dengue and yellow fever viruses induce differential anti-viral immune responses in human monocytic and first trimester trophoblast cells.
Autor: Luo H; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Winkelmann ER; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA., Fernandez-Salas I; Centro Regional de Salud Pública, Instituto Nacional de Salud Pública, Tapachula, Mexico., Li L; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA., Mayer SV; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA., Danis-Lozano R; Centro Regional de Salud Pública, Instituto Nacional de Salud Pública, Tapachula, Mexico., Sanchez-Casas RM; FMVZ/CIDICS, Universidad Autonoma de Nuevo Leon, Monterrey, NL, Mexico., Vasilakis N; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA., Tesh R; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA., Barrett AD; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA., Weaver SC; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA., Wang T; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX 77555, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: ti1wang@utmb.edu.
Publikováno v: Antiviral research [Antiviral Res] 2018 Mar; Vol. 151, pp. 55-62. Date of Electronic Publication: 2018 Jan 10.
Zobrazit plný text záznamu
9
Akademický článek
A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage.
Autor: Shan C; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, 77555, USA., Muruato AE; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA., Jagger BW; Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA., Richner J; Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA., Nunes BTD; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Ministry of Health, 67030-000, Ananindeua, Brazil., Medeiros DBA; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Ministry of Health, 67030-000, Ananindeua, Brazil., Xie X; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, 77555, USA., Nunes JGC; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Ministry of Health, 67030-000, Ananindeua, Brazil., Morabito KM; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Kong WP; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Pierson TC; Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, 20892, USA., Barrett AD; Institute for Human Infections & Immunity, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Department of Pathology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Center for Biodefense & Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX, 77555, USA., Weaver SC; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Institute for Translational Science, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, 77555, USA., Rossi SL; Institute for Human Infections & Immunity, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Department of Pathology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Center for Biodefense & Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, 77555, USA., Vasconcelos PFC; Department of Arbovirology and Hemorrhagic Fevers, Evandro Chagas Institute, Ministry of Health, 67030-000, Ananindeua, Brazil.; Department of Pathology, Pará State University, 67087-670, Belém, Brazil., Graham BS; Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, 20892, USA. bgraham@nih.gov., Diamond MS; Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA. diamond@wusm.wustl.edu.; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, 63110, USA. diamond@wusm.wustl.edu.; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA. diamond@wusm.wustl.edu.; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, 63110, USA. diamond@wusm.wustl.edu., Shi PY; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, 77555, USA. peshi@utmb.edu.; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX, 77555, USA. peshi@utmb.edu.; Institute for Translational Science, University of Texas Medical Branch, Galveston, TX, 77555, USA. peshi@utmb.edu.; Department of Pathology, Pará State University, 67087-670, Belém, Brazil. peshi@utmb.edu.; Department of Phamarcology & Toxicology, University of Texas Medical Branch, Galveston, TX, 77555, USA. peshi@utmb.edu.
Publikováno v: Nature communications [Nat Commun] 2017 Sep 22; Vol. 8 (1), pp. 676. Date of Electronic Publication: 2017 Sep 22.
Zobrazit plný text záznamu
10
Akademický článek
p38MAPK plays a critical role in induction of a pro-inflammatory phenotype of retinal Müller cells following Zika virus infection.
Autor: Zhu S; Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, TX, 77555, USA., Luo H; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA., Liu H; Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, TX, 77555, USA; Center for Biomedical Engineering, University of Texas Medical Branch, Galveston, TX, 77555, USA., Ha Y; Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, TX, 77555, USA., Mays ER; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA., Lawrence RE; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA., Winkelmann E; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA., Barrett AD; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA; Department of Pathology, University of Texas Medical Branch, Galveston, TX, 77555, USA., Smith SB; Cellular Biology and Anatomy, Augusta University, Augusta, GA, 30912, USA., Wang M; FutraTech Inc., San Diego, CA, 92121, USA., Wang T; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, 77555, USA. Electronic address: ti1wang@utmb.edu., Zhang W; Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, TX, 77555, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, 77555, USA; Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, 77555, USA. Electronic address: we2zhang@utmb.edu.
Publikováno v: Antiviral research [Antiviral Res] 2017 Sep; Vol. 145, pp. 70-81. Date of Electronic Publication: 2017 Jul 21.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje